Options Brief: Endo Pharmaceuticals Holdings (ENDP)

Shares of Endo Pharmaceuticals Holdings ENDP are higher on the session by 0.18%, trading at $38.01. Overall put volume is now running at 5.77x the daily average, with 0% of all puts traded being purchases on the offer. 1,529 contracts have traded on the session so far. Endo Pharmaceuticals Holdings Inc. is a specialty pharmaceutical company in pain management. The company is engaged in the research, development, manufacturing, marketing and sales of branded and generic pharmaceutical products used primarily to treat and manage pain, overactive bladder, prostate and bladder cancer and central precocious puberty.